摘要
目的:探讨胺碘酮治疗急诊危重症合并快速心律失常的临床效果.方法:将笔者所在医院2017年11月-2018年11月接收的76例急诊危重症合并快速心律失常患者作为研究对象,按照硬币两面法分为治疗组和对照组,给予对照组常规治疗,给予治疗组胺碘酮治疗,对两组不良反应发生率、临床应激指标、心功能指标、临床疗效进行评估.结果:治疗组不良反应发生率低于对照组,差异有统计学意义(P<0.05).治疗组临床应激指标及心功能指标均优于对照组,差异均有统计学意义(P<0.05).治疗组临床治疗总有效率高于对照组,差异有统计学意义(P<0.05).结论:对急诊危重症合并快速心律失常患者采用胺碘酮治疗,既能提高治疗安全性,改善患者临床指标及心功能指标,还能提高临床疗效,值得临床借鉴和推广.
Objective:To evaluate the clinical effect of Amiodarone in treatment of emergency critical illness with tachyarrhythmia.Method:From November 2017 to November 2018,76 cases of emergency critical patients with tachyarrhythmia in our hospital were selected,and were divided into the treatment group and the control group according to the coin two side method.The patients in the control group were given routine treatment,and the patients in the treatment group were given Amiodarone treatment.The incidence of adverse reactions,clinical stress index,cardiac function index and clinical effect of the two groups were evaluated.Result:The incidence of adverse reactions in the treatment group was lower than that in the control group,the difference was statistically significant(P<0.05).The clinical stress index and cardiac function index of the treatment group were better than those of the control group,and the difference was statistically significant(P<0.05).The clinical effective rate of the treatment group was higher than that of the control group,the difference was statistically significant(P<0.05).Conclusion:Amiodarone treatment can not only improve the safety of treatment,improve the clinical indicators and cardiac function indicators,but also improve the clinical efficiency,which is worthy of clinical reference and promotion.
作者
闵捷
MIN Jie(Ezhou Hospital of Traditional Chinese Medicine,Ezhou 436000,China)
出处
《中外医学研究》
2020年第8期138-140,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
胺碘酮
急诊危重症
快速心律失常
临床效果
不良反应
心功能指标
Amiodarone
Emergency critical illness
Tachyarrhythmia
Clinical effect
Adverse reaction
Heart function index
